Disease
6 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
AUG 14, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
Phase 1b registry record with recruitment completed but no results posted; describes planned efficacy and safety exploration in a small, dose-ranging study of a novel agent.
AUG 13, 2026 · PHASE 1/2 TRIAL
ClinicalTrials.gov
Phase 1/2 trial in early stage of recruitment with no results yet posted; primary outcomes are safety and dose-finding rather than efficacy.
AUG 12, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
This is a registry record for an ongoing Phase 2 trial with no results posted; it describes planned enrollment and design only, not efficacy or safety outcomes.
AUG 11, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
Phase 2 trial with surrogate endpoint (ORR) in a small, single-arm population; results not yet reported in this registry record.
AUG 7, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a clinical trial registry record describing a planned Phase 3 study with no results posted; the record documents study design and hypothesis only, not clinical outcomes.
AUG 7, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
This is a Phase 2, single-arm registry record with no reported results; it describes an adaptive design testing whether PD-L1–high resectable NSCLC patients can omit chemotherapy, but outcomes are not yet posted.